Retrospective evaluation of intraocular lenses in adults younger than 60 years.
Data from the U.S. Food and Drug Administration, the American Academy of Ophthalmology's National Eyecare Outcomes Network, and Storm Eye Institute databases were analyzed for short- and long-term safety and efficacy outcomes of intraocular lens (IOL) implantation in adults younger than 60 years and 60 years and older. Statistical analyses for significance were performed where appropriate. A comprehensive literature review was conducted to identify safety and efficacy outcomes and their relationship to patient age at the time of implantation. Analyses established that the performance of IOLs in adults younger than 60 years was comparable to that in adults older than 60 years and supported the use of IOLs in the younger adult population.
Boam
Ashley B
AB
U.S. Food and Drug Administration, Rockville, Maryland, USA.
Eydelman
Malvina B
MB
Lum
Flora C
FC
Silverman
Phyllis M
PM
Apple
David J
DJ
Werner
Liliana
L
Pandey
Suresh K
SK
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016208:Databases, Factual; D006801:Humans; D019654:Lens Implantation, Intraocular; D007910:Lenses, Intraocular; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D012189:Retrospective Studies; D012449:Safety; D014792:Visual Acuity / Q000502:physiology*